[EN] INHIBITORS OF TYPED 1 METHIONYL-TRNA SYNTHETASE AND METHODS OF USING THEM<br/>[FR] INHIBITEURS DE MÉTHIONYL-ARNT SYNTHÉTASE DE TYPE 1 ET LEURS MÉTHODES D'UTILISATION
申请人:UNIV WASHINGTON
公开号:WO2018237349A1
公开(公告)日:2018-12-27
The present disclosure is generally directed to compositions useful in the inhibition of MetRS and methods for treating diseases that are ameliorated by the inhibition of MetRS.
本公开涉及的是通常用于抑制MetRS的组合物和治疗通过抑制MetRS改善的疾病的方法。
Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against <i>Trypanosoma brucei</i>
作者:Zhongsheng Zhang、Ximena Barros-Álvarez、J. Robert Gillespie、Ranae M. Ranade、Wenlin Huang、Sayaka Shibata、Nora M. R. Molasky、Omeed Faghih、Aisha Mushtaq、Robert K. M. Choy、Eugenio de Hostos、Wim G. J. Hol、Christophe L. M. J. Verlinde、Frederick S. Buckner、Erkang Fan
DOI:10.1039/d0md00057d
日期:——
structures of Trypanosoma brucei methionyl-tRNA synthetase (TbMetRS) bound to inhibitors, we designed, synthesized, and evaluated two series of novel TbMetRS inhibitors targeting this parasite enzyme. One series has a 1,3-dihydro-imidazol-2-one containing linker, the other has a rigid fused aromatic ring in the linker. For both series of compounds, potent inhibition of parasite growth was achieved with
INHIBITORS OF TYPE l METHIONYL-TRNA SYNTHETASE AND METHODS OF USING THEM
申请人:UNIVERSITY OF WASHINGTON
公开号:US20210155617A1
公开(公告)日:2021-05-27
The present disclosure is generally directed to compositions useful in the inhibition of MetRS and methods for treating diseases that are ameliorated by the inhibition of MetRS.